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Background
HIV prevalence among transgender women is estimated
to be 50 times greater than that of nontransgender adults,
and yet HIV-positive transgender women exhibit low
rates of linkage to and retention in HIV primary care,
trends which are exacerbated among substance-using
and minority transgender women. Transgender women
experience a number of psychosocial challenges specific
to their gender identification, including discrimination,
prejudice, stigmatization, and social/economic marginali-
zation. Such issues stand as obstacles to engagement and
retention in medical care, substance abuse treatment,
and mental health and social services. Transgender
women report discrimination and/or blatant verbal abuse
at standard health-care facilities. In response to this
health disparity, The Alexis Project combines an innova-
tive application of Contingency Management (CM), in
conjunction with Peer Health Navigation (PHN), to
improve linkage to and retention in HIV primary care,
and achieve viral load suppression among HIV-infected
transgender women of color in Los Angeles County.
Methods
Between February 2014 and February 2016, the study will
enroll 140 HIV-infected transgender women of color who
have either: 1) never been in HIV care; 2) have dropped
out of HIV care; or 3) are nonadherent to current HIV
medications. Data collection began in February 2014;
current enrollment is N = 34. During the course of the
18-month intervention, participants can earn CM rewards
for confirmed linkage to HIV primary care (i.e., first HIV
care appointment), retention in HIV care (i.e., quarterly
HIV care appointments), and reaching HIV milestones (i.
e., fill antiretroviral [ART] medication prescription, medi-
cation adherence as confirmed by log reductions; HIV
viral load suppression). If a participant attends all of her
HIV care visits and reaches each verified HIV milestone,
she can earn $500 in CM rewards over the 18-month
intervention.
Results
To date, most participants self-identified as African
American/black (47.1%), Hispanic/Latino (32.4%), or
multi/other (17.6%), and the mean participant age was
35.4 (SD = 7.6). Less than half of the participants gradu-
ated from high school (44.1%), half reported current
homelessness (50%), and slightly over half reported a
prior AIDS diagnosis (52.4%). Most reported using Medi-
care/Medicaid/other public insurance (79.4.1%), and/or
attending a community or county clinic to receive health
care (50%), and just over one-third reported receiving
HIV primary care in the previous 6 months (38.1%). In
the past 6 months, 47.1 percent reported using metham-
phetamine, 27.3 percent reported ever using an ampheta-
mine, 25 percent reported using cocaine, and lifetime
injection drug use was 17.7 percent. Slightly under half
(42.9%) reported having ever been on ART. To date, 66.7
percent of the participants have been linked into HIV
care (i.e., attended their first HIV medical appointment);
41.2 percent have received their initial laboratory results
and filled their ART prescription. The mean enrollment-
to-linkage time has been 22.4 days (SD = 31.4; range =
0–148 days).
Conclusions
Preliminary data indicate that CM, in combination with
PHN, will be effective in linking HIV-infected transgender* Correspondence: reback@friendsresearch.org
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women of color into HIV primary care. Longitudinal data
of retention in care and ART medication adherence will
provide further indication of whether this novel applica-
tion of CM can produce viral load suppression and
improve the health outcomes of HIV-infected transgender
women of color.
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